Clinical Trials · NCT01707225
Safety Study of Octreotide Injection to Prevent GI Bleeding in Patients With Left Ventricular Assist Device (LVAD)
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Virginia Commonwealth University
- Enrollment
- 10
- Start date
- Feb 2013
- Locations
- 1 site, United States
- Primary endpoint
- Number of Participants With Side-Effects